Last 1,410 KRW
Change Today -15.00 / -1.05%
Volume 251.7K
058530 On Other Exchanges
Symbol
Exchange
KOSDAQ
As of 1:10 AM 12/19/14 All times are local (Market data is delayed by at least 15 minutes).

equisnzaroo co ltd (058530) Snapshot

Open
1,400
Previous Close
1,425
Day High
1,410
Day Low
1,355
52 Week High
09/5/14 - 1,980
52 Week Low
06/26/14 - 1,270
Market Cap
38.6B
Average Volume 10 Days
163.3K
EPS TTM
30.86
Shares Outstanding
27.4M
EX-Date
--
P/E TM
45.7x
Dividend
--
Dividend Yield
--
Current Stock Chart for EQUISNZAROO CO LTD (058530)

Related News

No related news articles were found.

equisnzaroo co ltd (058530) Related Businessweek News

No Related Businessweek News Found

equisnzaroo co ltd (058530) Details

EQUISnZAROO Co., Ltd. engages in the manufacture of automation equipment and information technology based drug discovery business. It manufactures PCB production equipment, including in line auto trimming systems, auto lay-up systems, MLB bonding, and x-ray drilling machines; loaders and unloaders, such as vertical type, rack type, vertical slip sheet extraction/insertion type, robot type, and box type, as well as provides washer line loaders; and wicket colling, stock, and pre-preg drilling products. It also develops lead compounds for diabetes, anti-viral, anti-cancer, and whitening agent, as well as focuses on bioinformatics and cheminformatics. The company’s bioinformatics services include gene prediction services using Geno technology, gene regulator region analysis and prediction using GenoMap technology, gene annotation using GenoInfo technology, and genome scale annotation and new drug target identification using GenoLinx technology under the IDGeno brand; and analysis of protein’s structural similarity using ProLinx technology, protein surface region and loop modeling services using ProBuild technology, and protein 3-D structure analysis and prediction using ProMaxT technology under the IDPro brand. Its cheminformatics services comprise prediction of physicochemical property using PharmoMap technology, virtual HTS services using PharmoScan technology, 3-D structural D/B services using PharmoDBT technology, and ADME/Tox using PreADME technology under the IDPharmo brand; and analysis of structural diversity using ChemoDiver technology, chemical library and customized chemical library services using ChemoLib technology and ChemoSet technology under the IDChemo brand. In addition, it operates special sports/outdoors shops that offer various sports equipment. The company was formerly known as Equispharm Co., Ltd and changed its name to EQUISnZAROO Co., Ltd. in 2010, as a result of its merger with ZAROO Inc. The company is headquartered in Ansan, South Korea.

equisnzaroo co ltd (058530) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

equisnzaroo co ltd (058530) Key Developments

EQUISnZAROO CO.,LTD, Annual General Meeting, Mar 22, 2013

EQUISnZAROO CO.,LTD, Annual General Meeting, Mar 22, 2013., at 09:00 Korea Standard Time. Location: Danwon-Seonggok-dong 728-3. Agenda: To approve the statement of financial position, income statement, statement of retained earnings; to consider incorporation of some changes; to approve election of directors; to approve appointment of audit Senior; to approve director approval of remuneration limit; to approve audit of remuneration limit; and to consider the number of shares of the options granted.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
058530:KS 1,410.00 KRW -15.00

058530 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 058530.
View Industry Companies
 

Industry Analysis

058530

Industry Average

Valuation 058530 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 1.8x
Price/Book 1.9x
Price/Cash Flow 111.6x
TEV/Sales 0.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact EQUISNZAROO CO LTD, please visit www.equispharm.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.